Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update
![]() |
MELBOURNE, Australia, Jan. 9, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference (9 – 12 January) in San Francisco.
As part of the Company's presentation (available to view or download from the investor page of the Telix...
Read more: Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update